ES8403441A1 - Procedimiento para preparar derivados de guanidina. - Google Patents

Procedimiento para preparar derivados de guanidina.

Info

Publication number
ES8403441A1
ES8403441A1 ES519403A ES519403A ES8403441A1 ES 8403441 A1 ES8403441 A1 ES 8403441A1 ES 519403 A ES519403 A ES 519403A ES 519403 A ES519403 A ES 519403A ES 8403441 A1 ES8403441 A1 ES 8403441A1
Authority
ES
Spain
Prior art keywords
radical
formula
compound
displaceable
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES519403A
Other languages
English (en)
Other versions
ES519403A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of ES519403A0 publication Critical patent/ES519403A0/es
Publication of ES8403441A1 publication Critical patent/ES8403441A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • C07D231/40Acylated on said nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • C07D257/06Five-membered rings with nitrogen atoms directly attached to the ring carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR DERIVADOS DE GUANIDINA, DE FORMULA GENERAL (I), EN LA QUE R1 Y R2, IGUALES O DIFERENTES, SON ATOMOS DE HIDROGENO O RADICALES ALQUILO; R3 ES UN ATOMO DE HIDROGENO O UN RADICAL ALQUILO; R4 ES UN RADICAL DE FORMULA HNR7, EN LA QUE R7 ES UN ATOMO DE HIDROGENO O UN RADICAL ALQUILO; EN EL ANILLO X LA LINEA DE PUNTOS ES UN ENLACE DOBLE; Z ES UN ATOMO DE CARBONO O DE NITROGENO; Y A ES UN RADICAL FENILENO O CICLOALQUILENO.CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA (III), EN LAS QUE G ES UN ATOMO DE OXIGENO ODE AZUFRE; R13 ES UN RADICAL DESPLAZABLE; Y A1 Y A2 SON RADICALES DESPLAZABLES.DE APLICACION COMO INHIBIDORES DE LA SECRECION DEL ACIDO GASTRICO.
ES519403A 1981-03-18 1983-01-31 Procedimiento para preparar derivados de guanidina. Expired ES8403441A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8108407 1981-03-18
GB8132680 1981-10-29

Publications (2)

Publication Number Publication Date
ES519403A0 ES519403A0 (es) 1984-03-16
ES8403441A1 true ES8403441A1 (es) 1984-03-16

Family

ID=26278795

Family Applications (4)

Application Number Title Priority Date Filing Date
ES510583A Granted ES510583A0 (es) 1981-03-18 1982-03-18 Derivados de guanidina.
ES519402A Expired ES8406424A1 (es) 1981-03-18 1983-01-31 Procedimiento para preparar derivados de guanidina.
ES519403A Expired ES8403441A1 (es) 1981-03-18 1983-01-31 Procedimiento para preparar derivados de guanidina.
ES519401A Granted ES519401A0 (es) 1981-03-18 1983-01-31 Procedimiento para preparar derivados de guanidina.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES510583A Granted ES510583A0 (es) 1981-03-18 1982-03-18 Derivados de guanidina.
ES519402A Expired ES8406424A1 (es) 1981-03-18 1983-01-31 Procedimiento para preparar derivados de guanidina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES519401A Granted ES519401A0 (es) 1981-03-18 1983-01-31 Procedimiento para preparar derivados de guanidina.

Country Status (18)

Country Link
US (1) US4795755A (es)
EP (1) EP0060697B1 (es)
AU (1) AU556079B2 (es)
CA (1) CA1200549A (es)
DD (1) DD202552A5 (es)
DE (1) DE3274856D1 (es)
DK (1) DK121282A (es)
ES (4) ES510583A0 (es)
FI (1) FI820882A7 (es)
GR (1) GR76470B (es)
IE (1) IE52764B1 (es)
IL (1) IL65160A (es)
IN (1) IN158869B (es)
NO (1) NO820870L (es)
NZ (1) NZ200042A (es)
PL (1) PL137088B1 (es)
PT (1) PT74599B (es)
ZW (1) ZW3682A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1233818A (en) * 1981-03-09 1988-03-08 David J. Gilman Guanidine derivatives as histamine h-2 receptor antagonists
CA1211111A (en) * 1982-02-15 1986-09-09 Isao Yanagisawa Process for preparing novel pyrimidone compounds
US4808589A (en) * 1982-02-20 1989-02-28 Smith Kline & French Laboratories Limited Pyrimidone derivatives
GB8316779D0 (en) * 1982-09-07 1983-07-27 Ici Plc Process
US4585781A (en) * 1982-12-31 1986-04-29 Glaxo Group Limited Heterocyclic derivatives
GB8401751D0 (en) * 1984-01-24 1984-02-29 Ici Plc Guanidine derivatives
GB8421427D0 (en) * 1984-08-23 1984-09-26 Smith Kline French Lab Chemical compounds
WO1994026715A1 (en) * 1993-05-11 1994-11-24 Smithkline Beecham Plc Amidine derivatives as gastric acid secretion inhibitors
EP2822931B1 (en) 2012-03-09 2017-05-03 Inception 2, Inc. Triazolone compounds and uses thereof
ES2660249T3 (es) 2012-12-20 2018-03-21 Inception 2, Inc. Compuestos de tipo triazolona y sus usos
JP2016529311A (ja) 2013-09-06 2016-09-23 インセプション 2、 インコーポレイテッド トリアゾロン化合物類及びそれらの使用
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2001624B (en) * 1977-04-20 1982-03-03 Ici Ltd Guanidine derivatives processes for their manufacture and pharmaceutical compositions containing them
BE866155A (fr) * 1977-04-20 1978-10-19 Ici Ltd Nouveaux derives de la guanidine
US4165378A (en) * 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
NZ186965A (en) * 1977-04-20 1980-02-21 Ici Ltd Guanidino derivatives and pharmaceutical compositions
JPS5444660A (en) * 1977-08-29 1979-04-09 Yamanouchi Pharmaceut Co Ltd Heterocyclic compound and its preparation
DE2835695A1 (de) * 1977-08-29 1979-03-15 Yamanouchi Pharma Co Ltd Neue heterocyclische verbindungen, verfahren zu ihrer herstellung und arzneimittel, die diese enthalten
JPS54132566A (en) * 1978-01-18 1979-10-15 Ici Ltd Guanidine derivative*its manufacture and secretion controlling pharmaceutical composition containing it
EP0006679B1 (en) * 1978-05-24 1982-07-21 Imperial Chemical Industries Plc Antisecretory thiadiazole derivatives, processes for their manufacture and pharmaceutical compositions containing them
EP0014057B1 (en) * 1979-01-18 1985-01-02 Imperial Chemical Industries Plc Guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
PH16099A (en) * 1979-03-06 1983-06-24 Yamanouchi Pharma Co Ltd Guanidinothiazole compounds,process for preparing them and medical composition containing them
JPS6056143B2 (ja) * 1979-08-02 1985-12-09 山之内製薬株式会社 アミジン誘導体ならびにその製造法
US4242351A (en) * 1979-05-07 1980-12-30 Imperial Chemical Industries Limited Antisecretory oxadiazoles and pharmaceutical compositions containing them
GR71929B (es) * 1979-11-13 1983-08-19 Ici Ltd
FI73423C (fi) * 1980-02-29 1987-10-09 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av farmakologiskt verksamma tetrazolderivat.
DE3168031D1 (en) * 1980-07-30 1985-02-14 Ici Plc Guanidine derivatives
GB2085871B (en) * 1980-08-08 1984-07-25 Kotobuki Seiyaku Co Ltd New 3-substituted-2-propenimidamides and method of manufacturing the same
EP0050407A1 (en) * 1980-08-27 1982-04-28 Glaxo Group Limited 3,5-Disubstituted-1,2,4-triazole compounds, processes for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DD202552A5 (de) 1983-09-21
ES8403440A1 (es) 1984-03-16
NZ200042A (en) 1985-08-30
US4795755A (en) 1989-01-03
PT74599A (en) 1982-04-01
ES519402A0 (es) 1984-07-16
CA1200549A (en) 1986-02-11
ES519403A0 (es) 1984-03-16
FI820882L (fi) 1982-09-19
FI820882A7 (fi) 1982-09-19
IN158869B (es) 1987-02-07
DE3274856D1 (en) 1987-02-05
ES8306476A1 (es) 1983-06-01
EP0060697B1 (en) 1986-12-30
NO820870L (no) 1982-09-20
EP0060697A1 (en) 1982-09-22
AU8113782A (en) 1982-09-23
AU556079B2 (en) 1986-10-23
PL137088B1 (en) 1986-04-30
DK121282A (da) 1982-09-19
PL235453A1 (en) 1983-03-28
IE820394L (en) 1982-09-18
ES519401A0 (es) 1984-03-16
ES510583A0 (es) 1983-06-01
IE52764B1 (en) 1988-02-17
ES8406424A1 (es) 1984-07-16
IL65160A (en) 1986-04-29
ZW3682A1 (en) 1983-10-26
PT74599B (en) 1983-11-07
GR76470B (es) 1984-08-10

Similar Documents

Publication Publication Date Title
ES8506612A1 (es) Un metodo para producir un derivado de amina
ES8307231A1 (es) Procedimiento para preparar derivados de piridona.
ES8704926A1 (es) Un procedimiento para la preparacion de derivados de benzotiazol y benzotiofeno
ES8706146A1 (es) Un procedimiento para preparar derivados de piridina
MX2023003053A (es) Pirazol[3,4-b]piridina-4-carboxamida inhibidor de la nitrificación.
ES8306750A1 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles.
ES8504738A1 (es) Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol
ES469265A1 (es) Procedimiento para la fabricacion de derivados del acido omega-aminoacilamisulfonico
ES8603837A1 (es) Un procedimiento para la preparacion de derivados de pirazol
MX9207603A (es) Deribados de acidos isoxazolcarboxilicos y procedimiento para su obtencion.
ES8402563A1 (es) Procedimiento para preparar derivados de guanidina.
GB1111989A (en) 2',3'-dideoxyriboside-2',3'-olefins
ES334174A1 (es) Procedimiento para preparar tioeteres.
DE3577093D1 (de) Beta-lactamantibiotika, verfahren zu deren herstellung sowie ihre verwendung als arzneimittel oder wachstumsfoerderer in der tieraufzucht oder als antioxidantien.
GB1075420A (en) Cyclic imide compounds and a process for their production
ES469353A1 (es) Un procedimiento para la preparacion de compuestos derivadosde bencimidazol
ES8306476A1 (es) Derivados de guanidina.
ES2061556T3 (es) Derivados amida y su produccion y fungicidas agricolas que los contienen.
FR2528433B1 (es)
ES8304125A1 (es) "un procedimiento para la preparacion de nuevos derivados de oxodiazolopirimidina".
ES8505962A1 (es) Un procedimiento para preparar nuevos derivados amidinicos de 4-fenilimidazol sustituido en la posicion 2
ES440532A1 (es) Procedimiento para la preparacion de derivados de 3-hidroxi-1, 2, 4-triazol.
ES8605471A1 (es) Procedimiento para preparar derivados de acido acrilico con actividad fungicida
ES375396A1 (es) Un procedimiento para la preparacion de nuevos acidos epo- xietilfosfonicos.
ES8201173A1 (es) Procedimiento para preparar alcohilfosfonoditioatos de o-a- rilo-s-alcohilo terciario